{
  "id": 7567673,
  "title": "Axoltis says its Phase 2 study for an experimental ALS drug failed",
  "url": "https://urgent.news/2026/09/15/axoltis-says-its-phase-2-study-for-an-experimental-als-drug-failed",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-15T14:16:53.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/axoltis-says-its-phase-2-study-for-an-experimental-als-drug-failed/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The French biotech Axoltis Pharma reported a Phase 2 failure in ALS on Tuesday morning, but suggested it found a small signal to move the drug forward amid a noisy dataset. Researchers were testing whether ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Vera kidney drug Trutakna shows strong final results in Phase 3 trial",
        "url": "https://urgent.news/2026/09/15/stat-vera-kidney-drug-trutakna-shows-strong-final-results-in-phase-3",
        "published": "2026-09-15T10:30:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}